Scopolamine (Hyoscine) Transdermal Patches Suppliers & Bulk Manufacturers
Available Forms: Transdermal patch
Available Strengths: 1.5 mg
Reference Brands: Transderm-Scop(US)
Category: Antiemetic
Scopolamine (Hyoscine) Transdermal Patches is available in Transdermal patch and strengths such as 1.5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Scopolamine (Hyoscine) Transdermal Patches is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Scopolamine (Hyoscine) Transdermal Patches can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Scopolamine patches, marketed as Transderm-Scop in the US and Scopoderm in the EU, are approved for preventing nausea and motion sickness. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For dossier guidance, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe use, and worldwide availability, helping patients manage nausea and motion sickness effectively across healthcare regions globally.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Dimenhydrinate Tablets
Strength:
50 mg, 100 mg
Form: Tablets
Reference Brands: Dramamine(US & EU)
View Details
Meclizine Tablet
Strength:
25 mg
Form: Tablets
Reference Brands: Antivert, Bonine, Dramamine(US)
View Details
Cyclizine Tablet
Strength:
50 mg
Form: Tablets
Reference Brands: Marezine, Cyclivert, and Bonine(US)
View Details
Netupitant + Palonosetron Capsules
Strength:
300 mg netupitant and 0.5 mg palonosetron
Form: Capsules
Reference Brands: Akynzeo(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
